Made-in-Canada approach to opioid addiction gets international attention
published on July 19, 2016 by The Canadian Press in CTV News
VANCOUVER – A made-in-Canada approach to treating opioid addiction is garnering positive international attention from one of the world’s most widely circulated medical publications.
The Journal of the American Medical Association has published a review of guidelines developed by a pair of health authorities in British Columbia aimed at educating health-care providers about how best to treat opioid-use disorder.
One of the guidelines’ authors, Dr. Keith Ahamad, says the protocols are the first to provide an evidence-based, gradual approach for how family doctors can best help someone addicted to opioids.
He says they suggest doing away with some traditional strategies that were found to be ineffective or even harmful.
The recommendations include discouraging rapid detoxification as a remedy and encouraging the use of Suboxone as a first-line treatment, rather than methadone.
Suboxone is a mixture of two drugs and has been shown in studies to be six-times safer than methadone, Ahamad says.
Dr. Evan Wood chaired the committee responsible for developing the guidelines, and says the medical journal’s recognition will hopefully generate interest and focus attention on the need to modernize addictions treatment.
“We spend huge money on the consequences of addiction, but we haven’t traditionally made the investments in a thoughtful approach to the prevention and effective treatment of addiction,” he says.
“Hopefully we’re beginning to turn the corner with that.”
Vancouver Coastal Health and Providence Health released the “Guideline for the Clinical Management of Opioid Addiction” in November 2015, several months before a surge in illicit drug deaths prompted BC’s chief doctor to declare a public-health emergency.View the full article